Basel Medical Group Ltd Ordinary Shares
BMGLNASDAQHealthcare● Active
$0.59
+$0.05(+9.20%)
Market Cap$11170007
P/E Ratio—
52W High$5.07
52W Low$0.383
Basel Medical Group Ltd Ordinary Shares (BMGL) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · BMGL · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-06 | 2024-06 | 2023-06 | 2022-06 |
|---|---|---|---|---|
| Revenue | ||||
| Revenue | $11.32M | $10.05M | $9.70M | $10.66M |
| Cost of Revenue | $2.53M | $2.25M | $2.34M | $2.18M |
| Gross Profit | $8.79M | $7.80M | $7.36M | $8.48M |
| Gross Margin %(computed) | 77.68% | 77.63% | 75.91% | 79.56% |
| Operating Expenses | ||||
| R&D Expenses | $0.00M | $0.00M | $0.00M | $0.00M |
| G&A Expenses | $6.54M | $3.64M | $3.27M | $4.04M |
| Total Operating Expenses | $10.98M | $5.61M | $5.36M | $6.01M |
| Operating Income | ($2.18M) | $2.20M | $2.00M | $2.47M |
| Operating Margin %(computed) | -19.28% | 21.84% | 20.64% | 23.21% |
| Interest Income | $0.08M | $0.00M | $0.30M | $0.25M |
| Interest Expense | $0.20M | $0.18M | $0.24M | $0.32M |
| Income Before Tax | ($12.51M) | $2.40M | $2.13M | $2.39M |
| Income Tax Expense | ($0.42M) | $0.33M | $0.35M | $0.41M |
| Net Income | ($12.09M) | $2.07M | $1.78M | $1.98M |
| Net Margin %(computed) | -106.78% | 20.62% | 18.38% | 18.56% |
| Per Share & EBITDA | ||||
| EPS (Basic) | $0.00 | $0.11 | $0.10 | $0.11 |
| Wtd Avg Shares | 0.00M | 18.75M | 18.75M | 18.75M |
| EBITDA | ($11.12M) | $3.11M | $2.93M | $3.28M |
| EBITDA Margin %(computed) | -98.24% | 30.94% | 30.17% | 30.80% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · SGD · M
Explore more Basel Medical Group Ltd Ordinary Shares data
About Basel Medical Group Ltd Ordinary Shares (BMGL) Income Statement
Basel Medical Group Ltd Ordinary Shares (BMGL) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, BMGL reported revenue of $0.01B, gross profit of $0.01B (gross margin 77.68%), and net income of ($0.01B) — a net profit margin of -106.78%.
Frequently asked questions
BMGL · 4 questionsBasel Medical Group Ltd Ordinary Shares (BMGL) reported revenue of $0.01B for 2025, up 12.6% year-over-year.
BMGL revenueBMGL salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09